EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • August 7th, 2015 • Arbutus Biopharma Corp • Pharmaceutical preparations • British Columbia
Contract Type FiledAugust 7th, 2015 Company Industry JurisdictionARBUTUS BIOPHARMA CORPORATION, a company incorporated under the laws of British Columbia (the “Company”), with offices at 100 – 8900 Glenlyon Parkway, Burnaby, British Columbia fax: (604) 419-3201
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • August 7th, 2015 • Arbutus Biopharma Corp • Pharmaceutical preparations • Pennsylvania
Contract Type FiledAugust 7th, 2015 Company Industry JurisdictionThis Executive Employment Agreement (“Agreement”) is made effective as of July 11, 2015 (the “Effective Date”) by and between OnCore Biopharma, Inc. (the “Company”), and Michael J. Sofia (the “Executive”) (together the “Parties”).
SHARE REPURCHASE AGREEMENTShare Repurchase Agreement • August 7th, 2015 • Arbutus Biopharma Corp • Pharmaceutical preparations • Delaware
Contract Type FiledAugust 7th, 2015 Company Industry JurisdictionThis Share Repurchase Agreement (“Agreement”) is made effective as of July 11, 2015 (the “Effective Date”) between Tekmira Pharmaceuticals Corporation (the “Company”), and Patrick T. Higgins (“Executive”) (together the “Parties”).
AGREEMENT TO SERVE AS CHIEF DEVELOPMENT OFFICERChief Development Officer Agreement • August 7th, 2015 • Arbutus Biopharma Corp • Pharmaceutical preparations • Pennsylvania
Contract Type FiledAugust 7th, 2015 Company Industry JurisdictionThis Agreement (the “Agreement”) is entered into as of May 29, 2015 (the “Effective Date”) by and between Tekmira Pharmaceuticals Corp., (the “Company”), and William T. Symonds (“Executive”).
THIRD AMENDMENT TO OPTION AGREEMENTOption Agreement • August 7th, 2015 • Arbutus Biopharma Corp • Pharmaceutical preparations • New York
Contract Type FiledAugust 7th, 2015 Company Industry JurisdictionThis THIRD AMENDMENT TO OPTION AGREEMENT (this “Third Amendment”), dated as of May 22, 2015, is by and among Monsanto Canada, Inc., a Canadian corporation (“Monsanto Canada”), Tekmira Pharmaceuticals Corporation, a British Columbia corporation (“Tekmira”), Protiva Biotherapeutics Inc., a British Columbia corporation (“Protiva”), and Protiva Agricultural Development Company Inc., a British Columbia corporation (the “Company”).
FIRST AMENDMENT TO PROTIVA-MONSANTO SERVICES AGREEMENTServices Agreement • August 7th, 2015 • Arbutus Biopharma Corp • Pharmaceutical preparations • New York
Contract Type FiledAugust 7th, 2015 Company Industry JurisdictionThis FIRST AMENDMENT TO PROTIVA-MONSANTO SERVICES AGREEMENT (this “First Amendment”), dated as of May 22, 2015, is by and among Protiva Biotherapeutics, Inc., a British Columbia corporation and a wholly-owned subsidiary of Tekmira Pharmaceuticals Corporation, a British Columbia corporation, (“Protiva”), Protiva Agricultural Development Company Inc. (“PadCo”), a British Columbia corporation and a wholly-owned subsidiary of Protiva (the “Company”), and Monsanto Company, a Delaware corporation (“Monsanto”). Protiva, the Company and Monsanto are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.